Shengsong Huang

389 Xin Cun Road
Xincun, 200065, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

LSMS-Net: Resolving multiple scattering via physics-constrained deep learning for photoacoustic imaging in porous media.

LSMS-Net: Resolving multiple scattering via physics-constrained deep learning for photoacoustic imaging in porous media.

Journal: Ultrasonics

Published: April 28, 2026

Supervised contrastive loss helps uncover more robust features for photoacoustic prostate cancer identification.

Supervised contrastive loss helps uncover more robust features for photoacoustic prostate cancer identification.

Journal: Frontiers in oncology

Published: March 25, 2025

Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND.

Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND.

Journal: Nature communications

Published: December 16, 2024

Perineural Invasion as a Risk Factor For Soft Tissue Progression in Patients With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Resistance.

Perineural Invasion as a Risk Factor For Soft Tissue Progression in Patients With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Resistance.

Journal: Clinical genitourinary cancer

Published: October 19, 2023

PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression.

PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression.

Journal: The Journal of clinical investigation

Published: August 22, 2023

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

Journal: Cell death & disease

Published: August 08, 2023

Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.

Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.

Journal: The Journal of clinical investigation

Published: April 26, 2023

Prospective role of 3βHSD1 in prostate cancer precision medicine.

Prospective role of 3βHSD1 in prostate cancer precision medicine.

Journal: The Prostate

Published: December 15, 2022

The clinical efficacy and limitations of dutasteride-regulated abiraterone metabolism in abiraterone-resistant patients: a prospective single-arm clinical trial in Chinese patients.

The clinical efficacy and limitations of dutasteride-regulated abiraterone metabolism in abiraterone-resistant patients: a prospective single-arm clinical trial in Chinese patients.

Journal: Translational andrology and urology

Published: June 27, 2022

Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors.

Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors.

Journal: Oncogene

Published: April 29, 2022

Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.

Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.

Journal: The Prostate

Published: March 18, 2022

Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment.

Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment.

Journal: Cell reports. Medicine

Published: December 08, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026